POLYMORPHISMS OF MATRIX METALLOPROTEASES 2 AND 9 GENES IN ASCENDING AORTA ANEURISM PATIENTS
https://doi.org/10.15829/1560-4071-2015-10-65-69
Abstract
Aim. To study the role of mononucleotide polymorphisms of the matrix metalloproteases genes MMP2 and MMP9 in the development of ascending aorta aneurism (AOA).
Material and methods. Totally 287 patients included with AOA and 227 persons of control group. All patients underwent echocardiography and assessment of mononucleotide gene polymorphisms of MMP2 (rs2285053) and MMP9 (rs11697325, rs2274755, rs17577) real-time, by PCR.
Results. The association of MMP9 (rs11697325) is confirmed for the formation of AOA. AA genotype was significantly more prevalent among AOA patients (c2 =7,2; p=0,01). AA genotype carriers had higher ascending aorta diameter comparing to other persons with different variants (p=0,02). The relation is shown of the polymorphism ММР2 (rs2285053) and AOA development. Persons with CC genotype were more prevalent in the group of the aorta pathology patients (c2 =7,0; р=0,03).
Conclusion. Genetic variants ММР9 and ММР2 can be additional risk factors of ascending aorta aneurism development. Therefore the assessment of different polymorphisms of matrix metalloproteases genes is useful for the risk stratification of the patients with ascending aorta dilation.
About the Authors
N. D. Gavrilyuk
North-Western Federal Medical Investigation Center, Saint-Petersburg
Russian Federation
Russian Federation
O. B. Irtyuga
North-Western Federal Medical Investigation Center, Saint-Petersburg
Russian Federation
Russian Federation
T. A. Druzhkova
North-Western Federal Medical Investigation Center, Saint-Petersburg
Russian Federation
Russian Federation
V. E. Uspensky
North-Western Federal Medical Investigation Center, Saint-Petersburg
Russian Federation
Russian Federation
A. B. Malashicheva
North-Western Federal Medical Investigation Center, Saint-Petersburg;
Saint-Petersburg State University
Russian Federation
Russian Federation
A. A. Kostareva
North-Western Federal Medical Investigation Center, Saint-Petersburg
Russian Federation
Russian Federation
O. M. Moiseeva
North-Western Federal Medical Investigation Center, Saint-Petersburg
Russian Federation
Russian Federation
References
1. WISQARS Leading Causes of Death Reports, 1999–2006. // HTTP://webappa.cdc.gov : National Center for Injury Prevention and Control. URL: http://webappa.cdc.gov/sasweb/ ncipc/leadcaus10.html (дата обращения: 22.04.2015).
2. Ehrlich MP, et al. Results of immediate surgical treatment of all acute type A dissections. Circulation 2000; 19 (Suppl III): 248-52.
3. Hiratzka LF, et al. Guidelines for the diagnosis and management of patients with thoracic aortic disease. J Am Coll Cardiol. 2010; 4: 127-29.
4. Irtyuga OB, Gavrilyuk ND, Voronkina IV, et al. Pathogenetic mechanisms of ascending aortic aneurysm of varied aetiology. Russ J Cardiol. 2013; 99(1): 14-8. Russian (Иртюга О. Б., Гаврилюк Н. Д., Воронкина И. В. и др. Механизмы формирования аневризмы восходящего отдела аорты различной этиологии. Российский кардиологический журнал. 2013; 99(1): 14-8).
5. Kostina DA, Voronkina IV, Smagina LV, et al. Functional properties of smooth muscle cells in ascending aortic aneurysm. Cytologia 2013; 55(10) 725-31
6. Iakoubova OA, Elefteriades JA, et al. Genetic Variants in FBN-1 and Risk for Thoracic Aortic Aneurysm and Dissection. PLoS One 2014; 4: 438-512.
7. Yetman AT, Graham T. The dilated aorta in patients with congenital cardiac defects. J Am Coll Cardiol. 2009; 6: 461-67.
8. Linhartov? K, et al. Aortic stenosis severity is not a risk factor for poststenotic dilatation of the ascending aorta. Circ J. 2007; 1: 84-8.
9. Robicsek F, et al. The congenitally bicuspid aortic valve: how does it function? Why does it fail? Ann Thorac Surg. 2004; 1: 177-85.
10. Ikonomidis JS, et al. Aortic dilatation with bicuspid aortic valves: cusp fusion correlates to matrix metalloproteinases and inhibitors . Ann Thorac Surg. 2012; 2: 457-63.
11. Duellman T, Warren CL, Peissig P, et al. Matrix metalloproteinase-9 genotype as a potential genetic marker for abdominal aortic aneurysm. Circ Cardiovasc Genet. 2013; 5: 529-37.
12. Yamada Y, et al. Association of a matrix metallopeptidase 1 gene polymorphism with longterm outcome of thoracic aortic aneurysm. International journal of molecular medicine 2012; 3: 125-32.
13. Rodr?guez I.et al. Low transcriptional activity haplotype of matrix metalloproteinase 1 is less frequent in bicuspid aortic valve patients. Gene 2012; 3: 304-8.
14. LeMaire A, et al. A single nucleotide polymorphism in the matrix metalloproteinase 9 gene (?8202A/G) is associated with thoracic aortic aneurysms and thoracic aortic dissection. J Thorac Cardiovasc Surg 2006; 5: 1045-52.
15. Price SJ, Greaves DR, Watkins H. Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem 2001; 5: 7549-58.
Review
For citations:
Gavrilyuk N.D., Irtyuga O.B., Druzhkova T.A., Uspensky V.E., Malashicheva A.B., Kostareva A.A., Moiseeva O.M. POLYMORPHISMS OF MATRIX METALLOPROTEASES 2 AND 9 GENES IN ASCENDING AORTA ANEURISM PATIENTS. Russian Journal of Cardiology. 2015;(10):65-69. (In Russ.) https://doi.org/10.15829/1560-4071-2015-10-65-69
Views:
805
Email this article 